Recent advances in the neuropsychopharmacology of serotonergic hallucinogens

Halberstadt, Adam L.·2015·Behavioural Brain Research
DOI 10.1016/j.bbr.2014.07.016

Cited by (316)

Items 301–316 of 316

  1. In-silico toxicity study of tryptamine, psilocin, psilocybin, N,N-dimethyltryptamine, 5’-methoxy-N,N-dimethyltryptamine and O-acetylpsilocin
    Kamil Jurowski, Damian Kobylarz, Maciej Noga · 2026 · Archives of Toxicology
  2. Dynamical circular inference in the general population and the psychosis spectrum : insights from perceptual decision making
    Pantelis Leptourgos · 2018 · theses.fr (ABES)
  3. Contribution du récepteur 5-HT2B dans la transmission sérotoninergique
    Emily Quentin · 2017 · theses.fr (ABES)
  4. A systematic review of the pharmacokinetics of classical serotonergic psychedelic compounds in healthy adult subjects
    Elliot Hampsey, Kirsty Martin, Michail Kalfas, L E Benson, Sirid Wihlborg, Luke A. Jelen, Allan Hunter Young, James Rucker · 2026 · Journal of Psychopharmacology
  5. Psychedelics and autism spectrum disorder: Mechanistic insights, translational evidence and ethical challenges
    Júlio César Claudino dos Santos, Sofia Januário Bolan, Guilherme Lodetti da Silva, Germano Lapa Viana, Eduardo Pacheco Rico, Cinara Ludvig Gonçalves · 2026 · Journal of Psychiatric Research
  6. Research progress of depression and pain comorbidity: Animal model, mechanism, treatment strategy
    Qi Li, Liuyi Ren, Kun Tu, ZhongXiang Zhang, Xuping Yang, Min Li, Longyang Jiang, Shurong Wang, Jie Zhou · 2026 · Brain Research Bulletin
  7. Mechanisms of Action and Change in Psychedelic-Assisted Therapies: A Holistic Framework for Ethical, Competent Clinical Care
    Lynnette A. Averill, Logan Neitzke‐Spruill · 2026 · FOCUS The Journal of Lifelong Learning in Psychiatry
  8. Classic Psychedelics for Treating Chronic Pain: Mechanism and Clinical Translation
    Hongyu Chen, Bowen Ke, Ruotian Jiang · 2026 · Molecules
  9. Convergent neuroimmune signaling underlying rapid antidepressant response to ketamine and psychedelics
    Gregory H. Jones, Jessica R. Gilbert, Jenessa N. Johnston, Nirmala Akula, Anton Schulmann, Miranda H. Arakelian, Shiyong Peng, Peixiong Yuan, Ewurakua A. Winful, Mani Yavi et al. · 2026 · Molecular Psychiatry
  10. Antinociceptive effect of N,N-dimethyltryptamine (DMT) involving serotonergic, opioidergic, cannabinoidergic, and nitrergic systems in PGE2-induced hyperalgesia in rats
    Flávia Cristina de Sousa Fonseca, Daniel Portela Dias Machado, André D. Cavalcante, Andrea C. Perez, Thiago Roberto Lima Romero, Igor Dimitri Gama Duarte · 2026 · Journal of Pain Research and Management
  11. A circuit dissection of perception–action decoupling in S-ketamine-induced hallucination-like states
    Dijia Wang, junnan Xu, Zhaoran Wang, Zhirui Liu, Ziqing He, Tianjie Xu, Bin Mei, Jiqian Zhang, Hu Liu, Zhilai Yang et al. · 2026 · Molecular Psychiatry
  12. Investigation of the pharmacological and circuit basis for psychedelic drug effects on interval timing in mice
    Landon M. Klein, Jared M. Kopelman, Richard F. Sharp, Susan B. Powell, Mark A. Geyer, Jared W. Young, Adam L. Halberstadt · 2026 · Psychopharmacology
  13. BindingDB Entry 50010680: Discovery of a lead series of potent benzodiazepine 5-HT
    BindingDB · 2021 · UC San Diego
  14. BindingDB Entry 50023820: Diazepine Agonists of the 5-HT2C Receptor with Unprecedented Selectivity: Discovery of Bexicaserin (LP352).
    BindingDB · 2026 · UC San Diego
  15. BindingDB Entry 50012418: Novel (R)-6,6a,7,8,9,10-hexahydro-5H-pyrazino[1,2-a][1,n]naphthyridines as potent and selective agonists of the 5-HT
    BindingDB · 2022 · UC San Diego
  16. BindingDB Entry 50011704: Design and Discovery of Functionally Selective Serotonin 2C (5-HT
    BindingDB · 2022 · UC San Diego